LAM
Lewis Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Sell |
18,400
-1,600
| -8% | -$46K | 0.25% | 98 |
|
|
2025
Q1 | $671K | Buy |
20,000
+10,220
| +104% | +$343K | 0.55% | 48 |
|
|
2024
Q4 | $500K | Sell |
9,780
-2,395
| -20% | -$122K | 0.38% | 64 |
|
|
2024
Q3 | $622K | Sell |
12,175
-220
| -2% | -$11.2K | 0.45% | 58 |
|
|
2024
Q2 | $555K | Buy |
+12,395
| New | +$555K | 0.42% | 56 |
|